The Impeachment Drivers Are Counting on the 'Stupidity of

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone dbergh #30058
124
The Impeachment Drivers Are Counting on
the 'Stupidity of the American Voter < >

6a7d2689-a635-48fe-b48b-a7ac97b5f208.png

Adam Schiff is the new Jonathan Gruber. Remember Jonathan Gruber? Professor Jonathan Holmes Gruber is the MIT economist who is credited as being the “architect” of the Patient Protection and Affordable Care Act (“ObamaCare”).

Gruber did the unthinkable. He committed the ultimate Washington “gaffe." He told the truth. After ObamaCare was enacted, he revealed the deviousness of his party’s thought processes in its formulation. He did this in braggadocious moments, opining before like-minded “intellectuals” in academic settings, around whom he no doubt felt at ease and could “open up,” never considering how a video record of his comments would appear to his fellow Americans.

On numerous occasions since the passage of the awful and unconstitutional ObamaCare, Gruber has confessed that the ObamaCare legislation was written by its Democrat creators with deception at its core and with the understanding that the American people are, in Gruber’s words, “stupid.”

In one setting, Gruber explained how the ACA was written to engage in taxman’s sleight-of-hand so that insurance companies, rather than individual taxpayers, would bear the brunt of a 40 percent tax increase on health care benefits, although noting that the net effect on taxpayers would be the same. But, as the good professor noted, the American people would be “too stupid to know the difference.” He also said, “Lack of transparency is a huge political advantage.”
CARTOONS | Bob Gorrell
View Cartoon

Jonathan Gruber understood something that Democrats, as well as Communists, Marxists, and Socialists the world over have long understood: the power of the lie.

Today, we have Jonathan Gruber 2.0 in Rep. Adam Schiff.

Through a faux impeachment process headed by Schiff, we’re seeing the same sort of mass deception that occurred with the formulation of ObamaCare. This time, the grand lie through which the Democrats hope to dupe the American populace is the “impeachment inquiry” they are carrying out in a spectacle worthy of Vladimir Ilyich Lenin. Or perhaps Adolph Hitler’s propaganda minister, Joseph Goebbels. It should make the skin crawl of any American with an iota’s worth of understanding of history and tyranny.

This is not a real impeachment process, as established through over 150 years of precedence, beginning with Andrew Johnson in 1868. As constitutional scholars David Rivkin and Elizabeth Price Foley laid out in a brilliant Wall Street Journal legal dissection titled “This Impeachment Subverts the Constitution,” Speaker Nancy Pelosi and Rep. Adam Schiff are engaging in extraordinary extra-constitutional proceedings. They pursued an ersatz impeachment-like process for actions by the president which were not impeachable crimes, in an inquiry that was not authorized by a full vote of the House of Representatives, in secret hearings that were completely slanted to one political party, based on allegations made by an anonymous, politically biased “whistleblower” who had no first-hand knowledge about a presidential phone call over which he was “blowing the whistle.”

The entire process is otherworldly. After a declaration by fiat on September 24 that she had launched a “formal impeachment inquiry”, absent any vote by the House, and then taking one-sided depositions in secret in a sub-basement of the Capitol, with no opportunity for the President to have counsel present to cross-examine witnesses, Speaker Pelosi decided at the 11th hour to hold a “vote” in the House, fittingly on Halloween, to approve “rules” regarding a process that was already far along. Bizarre doesn’t begin to describe what is occurring.

In the same way that Jonathan Gruber had to trick the American people into thinking that they wouldn’t be slammed with massive increases in their health care premiums by saddling them on a middleman, the House Halloween vote on impeachment procedures was meant to trick the American people into thinking that their party’s already advanced, biased proceedings would magically be transformed into a legitimate impeachment process.

The result of that Halloween vote produced rules for the faux-impeachment hearings which are as fundamentally flawed as ever. In the open hearings, Intelligence Committee Chairman Schiff can question witnesses for 45 minutes, whereas Republican members are limited to five minutes of questioning. Schiff can call whatever witnesses he wants, whereas Republican members must submit a list of the witnesses they want to call and obtain Schiff’s approval. As Rep. Jim Jordan told Maria Bartiromo, “You can try to put a ribbon on a sham process, but that doesn’t make it any less of a sham.”

To add insult to constitutional injury, Congresswoman Katie Porter from California, naturally, wore a Batman outfit to vote on a matter that our Founders intended to be among the most serious and sober that the House of Representatives could contemplate: removing a sitting president through the impeachment process.
Recommended
Dear GOP In Congress: Put Up or Shut Up
Sheriff David Clarke, Ret.

But the Golden State wasn’t done with its contributions to the Republic. Also voting to approve the grossly flawed impeachment resolution that day in the freak show vote was freshman Democratic Congresswoman Katie Hill, who had only that week announced her resignation from the House following revelations of her affairs with both male and female staff members in her office. The “rising star in the Democratic Party” proudly announced that she would make her final floor speech in the House following the vote. Perhaps after that, she would return to her office for a final hit from her bong. California, you must be so proud.

Just as Jonathan Gruber’s ObamaCare passed the Senate by a party-line vote on Christmas Eve 2009, Adam Schiff’s impeachment proceedings resolution passed by a virtual party-line vote on All Hallows Eve (with two Democrats, still clinging to political sanity and wanting to retain their seats in moderate congressional districts, voting with the Republicans.)

If Obamacare, which caused the Democrats to lose the House in 2010 by the largest net shift in seats in 62 years, is any guide, impeachment may prove to be an enormous gift for Donald J. Trump.

William F. Marshall has been an intelligence analyst and investigator in the government, private, and non-profit sectors for more than 30 years. He is a senior investigator for Judicial Watch, Inc., the host of the JW podcast Inside Report, and a contributor to Townhall, American Thinker, and The Federalist. (The views expressed are the author’s alone, and not necessarily those of Judicial Watch.)
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 221

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 79

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 189

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 118

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 85

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 129

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 389

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 0

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 159

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 166

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading

Top 5 Most Recently Viewed Articles

Vor Bio's Exploration of Strategic Alternatives for Growth

Updated Category News Views 213

Vor Bio Announces Exploration of Strategic Alternatives Today, Vor Bio, a clinical-stage cell and genome engineering company, has taken significant steps to enhance shareholder value. The decision comes at a time when the clinical data from its major programs suggests that reevaluating its approach could be beneficial in the face of challenging fundraising conditions....

Continue Reading
Kraig Biocraft Achieves Record Production in Spider Silk Fibers

Updated Category News Views 56

Kraig Biocraft Laboratories' Milestone in Spider Silk Production Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB), a pioneering firm renowned for its innovative developments in spider silk-based fibers, is thrilled to share the successful conclusion of its fourth production cycle for the year. This cycle represents a remarkable achievement, showcasing record-breaking...

Continue Reading
Gen X Faces Retirement Challenges: Understanding the Crisis

Updated Category News Views 282

Gen X’s Coming Retirement Crunch Gen X—often called the “sandwich generation”—is being pulled in two directions at once and edging toward a retirement problem many don’t fully see. With money, time, and attention split between family and work, long-term savings can drift to the back burner. The worry isn’t abstract; it’s about whether the money will be...

Continue Reading
Luxurious Villa Spectre: A $55 Million Icon of Elegance

Updated Category News Views 342

Villa Spectre: A $55 Million Marvel of Luxury Living Villa Spectre has recently captured the spotlight as the highest-priced sale in the area, setting a remarkable benchmark in luxury real estate. This impressive estate was sold for $55,000,000, showcasing the allure and opulence that the elite have come to expect from high-end properties. A Visionary Creation Designed by...

Continue Reading
Mosaic Minerals Shifts Focus to Gold with Amanda Acquisition

Updated Category News Views 333

Mosaic Minerals Re-prioritizes Focus on Gold Exploration Mosaic Minerals Corporation (CSE: MOC) is making a strategic pivot in its exploration efforts. The company has announced the cessation of its lithium exploration initiatives, particularly those in Jamésie, Quebec. Instead, Mosaic is setting its sights on more promising ventures in gold and nickel, specifically...

Continue Reading